Yousif Capital Management LLC Cuts Stake in Veradigm Inc. (NASDAQ:MDRX)

Yousif Capital Management LLC decreased its position in Veradigm Inc. (NASDAQ:MDRX) by 4.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 54,611 shares of the software maker’s stock after selling 2,255 shares during the period. Yousif Capital Management LLC’s holdings in Veradigm were worth $573,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Pacer Advisors Inc. boosted its holdings in Veradigm by 108.1% in the 4th quarter. Pacer Advisors Inc. now owns 2,516,574 shares of the software maker’s stock valued at $26,399,000 after purchasing an additional 1,307,024 shares in the last quarter. Wellington Management Group LLP boosted its stake in shares of Veradigm by 92.5% in the third quarter. Wellington Management Group LLP now owns 2,665,814 shares of the software maker’s stock valued at $35,029,000 after buying an additional 1,281,319 shares in the last quarter. William Blair Investment Management LLC grew its holdings in Veradigm by 16.6% during the third quarter. William Blair Investment Management LLC now owns 4,375,005 shares of the software maker’s stock worth $57,488,000 after acquiring an additional 623,438 shares during the period. Creative Planning grew its holdings in Veradigm by 2,848.4% during the third quarter. Creative Planning now owns 474,376 shares of the software maker’s stock worth $6,233,000 after acquiring an additional 458,287 shares during the period. Finally, abrdn plc purchased a new position in Veradigm in the fourth quarter worth $4,496,000.

Veradigm Price Performance

Shares of NASDAQ MDRX opened at $7.70 on Monday. The company’s 50-day moving average price is $7.70 and its 200 day moving average price is $9.66. Veradigm Inc. has a 52 week low of $5.01 and a 52 week high of $14.09.

Analysts Set New Price Targets

MDRX has been the topic of several research analyst reports. Deutsche Bank Aktiengesellschaft restated a “hold” rating and set a $10.00 target price (down from $15.00) on shares of Veradigm in a research report on Tuesday, March 19th. StockNews.com started coverage on shares of Veradigm in a research report on Wednesday, May 1st. They set a “hold” rating on the stock. Finally, Royal Bank of Canada reduced their price target on shares of Veradigm from $22.00 to $11.00 and set an “outperform” rating for the company in a research report on Friday, January 19th. Five investment analysts have rated the stock with a hold rating and one has given a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $11.25.

About Veradigm

Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.